<DOC>
	<DOCNO>NCT00621335</DOCNO>
	<brief_summary>The objective research study compare tolerability effectiveness Combigan ( brimonidine tartrate/timolol maleate ) Cosopt ( dorzolamide hydrochloride ) treatment open angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>A Investigator Masked Parallel Comparison Tolerability Combigan Cosopt</brief_title>
	<detailed_description>Patients age 40 90 year age , diagnose open angle glaucoma ocular hypertension , include pseudo-exfoliation pigmentary glaucoma definitive glaucomatous optic disk cup and/or glaucomatous visual field loss , receive stable treatment regime least 4 week prior study initiation , Cosopt mono Prostaglandin + Cosopt combination include study.Patients must IOP 16 32 mmHg , read 35 mmHg baseline . Patients form glaucoma primary open angle glaucoma , gonioscopy measure angle grade less 2 , visual field defect glaucomatous origen previous cyclodestructive procedure excluded.The use ocular non steroidal anti-inflammatory topical agent inhibit cyclooxygenase prostaglandin analog synthesis , use glucocorticoid therapy , hypersensitivity study component also preclude involvement study . Any ocular laser therapy within past three month , ocular inflammation infection past three month history trauma last six month also exclude enrollment study .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Brimonidine Tartrate , Timolol Maleate Drug Combination</mesh_term>
	<criteria>open angle glaucoma ocular hypertension include pseudoexfoliation pigmentary glaucoma definitive glaucomatous optic disk cup and/or glaucomatous visual field loss stable treatment regime least 4 week prior study initiation , Cosopt mono Prostaglandin + Cosopt combination IOP 16 32 mmHg , read 35 mmHg baseline form glaucoma primary open angle glaucoma gonioscopy measure angle grade le 2 visual field defect glaucomatous origen previous history cyclodestructive procedure use ocular non steroidal antiinflammatory topical agent inhibit cyclooxygenase prostaglandin analog synthesis use glucocorticoid therapy hypersensitivity study component ocular laser therapy within past three month ocular inflammation infection past three month history trauma last six month</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Open angle glaucoma</keyword>
	<keyword>Ocular hypertension</keyword>
	<keyword>Parallel comparison</keyword>
	<keyword>Combigan</keyword>
	<keyword>Cosopt</keyword>
</DOC>